| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5573 nt | 0.3752 | |
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5406 nt | 0.3716 | |
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5756 nt | 0.3777 | |
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5503 nt | 0.3727 | |
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5760 nt | 0.3778 | |
| GCACUGAGCCUAAGCAGCCGGUGAUGGCGGCAGCGGCUGUGGUGGCUGC… | 5428 nt | 0.3716 |
This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]
A study in mice demonstrated that chronic methamphetamine administration significantly dysregulates the RPS6KB1 in microglia, as part of a broad disruption of autophagy pathways revealed by single-cell RNA sequencing [Oladapo et al. DOI:10.3390/Ijms26020649].